Tango Therapeutics Q2 EPS $(0.37) Misses $(0.32) Estimate
Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.32) by 15.62 percent. This is a 5.71 percent decrease over losses of $(0.35) per share
Tango Therapeutics lost more money per share than experts predicted, meaning the company is spending cash faster than expected. When a company loses more than people thought, it can make investors worry about how long the money will last.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.